TGFB1 and systemic lupus erythematosus: Studies have pointed out that several cytokines, chemokines, or growth factors have been utilized to determine the clinical pathogenesis of SLE patients [8], including interleukin subfamily, CC chemokine ligand (CCL) subfamily, transforming growth factor-β (TGFβ), etc. [39].